ACH
ALBO
ArrowMark Colorado Holdings’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-786,664
| Closed | -$17M | – | 333 |
|
2022
Q4 | $17M | Sell |
786,664
-4,585
| -0.6% | -$99.1K | 0.2% | 99 |
|
2022
Q3 | $15.3M | Buy |
791,249
+184,286
| +30% | +$3.57M | 0.19% | 111 |
|
2022
Q2 | $12.1M | Sell |
606,963
-33,930
| -5% | -$674K | 0.14% | 139 |
|
2022
Q1 | $19.1M | Buy |
640,893
+4,547
| +0.7% | +$136K | 0.17% | 122 |
|
2021
Q4 | $14.8M | Buy |
636,346
+6,769
| +1% | +$158K | 0.12% | 146 |
|
2021
Q3 | $19.6M | Sell |
629,577
-52,424
| -8% | -$1.64M | 0.15% | 128 |
|
2021
Q2 | $24M | Sell |
682,001
-16,746
| -2% | -$589K | 0.18% | 120 |
|
2021
Q1 | $24.6M | Sell |
698,747
-52,748
| -7% | -$1.86M | 0.18% | 118 |
|
2020
Q4 | $28.2M | Sell |
751,495
-47,069
| -6% | -$1.77M | 0.22% | 106 |
|
2020
Q3 | $26.6M | Sell |
798,564
-158,426
| -17% | -$5.29M | 0.25% | 92 |
|
2020
Q2 | $25.4M | Sell |
956,990
-15,382
| -2% | -$407K | 0.26% | 89 |
|
2020
Q1 | $15.9M | Buy |
972,372
+105,322
| +12% | +$1.72M | 0.21% | 99 |
|
2019
Q4 | $22M | Buy |
867,050
+243,670
| +39% | +$6.19M | 0.2% | 105 |
|
2019
Q3 | $12.5M | Buy |
623,380
+67,652
| +12% | +$1.35M | 0.12% | 139 |
|
2019
Q2 | $17.9M | Sell |
555,728
-104,714
| -16% | -$3.38M | 0.17% | 116 |
|
2019
Q1 | $21.3M | Buy |
660,442
+48,450
| +8% | +$1.56M | 0.2% | 107 |
|
2018
Q4 | $15M | Buy |
611,992
+55,925
| +10% | +$1.37M | 0.16% | 123 |
|
2018
Q3 | $18.3M | Buy |
556,067
+42,818
| +8% | +$1.41M | 0.15% | 126 |
|
2018
Q2 | $18.2M | Buy |
513,249
+107,897
| +27% | +$3.83M | 0.17% | 121 |
|
2018
Q1 | $13.2M | Buy |
+405,352
| New | +$13.2M | 0.13% | 145 |
|